X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: It is Medicare’s birthday month!

By Nicole Longo  |    July 3, 2017
On July 30, 1965, Medicare was signed into law by President Lyndon B. Johnson, so this week we’re kicking off Medicare’s birthday month with a look back at some of our favorite resources.   Read More

Medicare Monday: 3 reasons why repealing Part D’s noninterference clause is a bad idea

By Nicole Longo  |    June 26, 2017
A number of proposals have been thrown around as part of the health care debate. One idea is to repeal the noninterference clause in Medicare Part D. Doing so would allow the Secretary of Health...   Read More

Medicare Monday: How government price setting in Part D could reduce innovation, shorten life expectancy for beneficiaries

By Nicole Longo  |    June 19, 2017
Today, we are diving into the conversation about how government price setting proposals could impact the Medicare Part D program and beneficiaries. Imposing Veterans Administration (VA)-style...   Read More

Medicare Monday: New report highlights progress in fighting cancer with new physician-administered medicines

By Nicole Longo  |    June 12, 2017
We’ve seen significant progress in recent years in the treatment of cancer, and that progress is expected to continue. A new report released this month found that there are more than 240 new...   Read More

Medicare Monday: Positive impact of Part D on America’s seniors

By Nicole Longo  |    June 5, 2017
Implementation of Medicare Part D significantly increased access to medicines for seniors and for those under age 65 with permanent disabilities. Since then, Part D has contributed to significant...   Read More

Medicare Monday: Catch up on MedPAC and its Part B recommendations

By Nicole Longo  |    May 29, 2017
A long weekend is the perfect time to catch up on your reading list. For policy wonks, you can get up to speed with our Memorial Day reading list on the Medicare Payment Advisory Commission...   Read More

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

By Nicole Longo  |    May 22, 2017
We often discuss the creation of Part D when we talk about the market-based changes that the Medicare Modernization Act (MMA) made to Medicare, but that’s just one example. Today, let’s take a...   Read More

Medicare Monday: Why imposing Medicaid-style rebates in Part D is a bad idea

By Nicole Longo  |    May 15, 2017
We’ve talked a lot about how repealing the non-interference clause in Medicare Part D would negatively impact beneficiaries. But there are other proposals to fundamentally alter the structure of...   Read More

Medicare Monday: How finding an Alzheimer’s treatment could lower Medicare spending

By Nicole Longo  |    May 8, 2017
Alzheimer’s disease is devastating and impacts more than 5.5 million Americans and their families. While America’s biopharmaceutical researchers have been working tirelessly to find a cure for the...   Read More

Medicare Monday: What the experts are saying about the Independent Payment Advisory Board

By Nicole Longo  |    May 1, 2017
The Independent Payment Advisory Board (IPAB), a panel of 15 members selected by the President and confirmed by the Senate, is tasked with proposing cuts to Medicare if spending exceeds a certain...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates